Last updated on July 2019

Safety and Efficacy of Emixustat in Stargardt Disease

Brief description of study

The purpose of this study is to determine if emixustat hydrochloride reduces the rate of progression of macular atrophy compared to placebo in subjects with Stargardt disease.

Clinical Study Identifier: NCT03772665

Find a site near you

Start Over

UCSF Dept. of Ophthalmology

San Francisco, CA United States
  Connect »

Emory University

Atlanta, GA United States
  Connect »

Mayo Clinic Rochester

Rochester, MN United States
  Connect »

Duke Eye Center

Durham, NC United States
  Connect »

Casey Eye Institute - OHSU

Portland, OR United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.